Oncologic outcomes of surgery in t3 prostate cancer: experience of a single tertiary center

about

Oncologic outcomes of surgery in t3 prostate cancer: experience of a single tertiary center

Item

http://www.wikidata.org/entity/Q35642310

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Oncologic outcomes of surgery ...... ce of a single tertiary center

@ast

Oncologic outcomes of surgery ...... ce of a single tertiary center

@en

type

Item

label

Oncologic outcomes of surgery ...... ce of a single tertiary center

@ast

Oncologic outcomes of surgery ...... ce of a single tertiary center

@en

prefLabel

Oncologic outcomes of surgery ...... ce of a single tertiary center

@ast

Oncologic outcomes of surgery ...... ce of a single tertiary center

@en

P1476

Oncologic outcomes of surgery ...... ce of a single tertiary center

@en

P2093

D Milonas

http://www.w3.org/2001/XMLSchema#string

G Smailyte

http://www.w3.org/2001/XMLSchema#string

M Jievaltas

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer.

Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience.

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials.

Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone.

Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).

P304

164263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/164263

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51980106

http://www.w3.org/2001/XMLSchema#string

P698

22216025

http://www.w3.org/2001/XMLSchema#string

P932

3248758

http://www.w3.org/2001/XMLSchema#string